INMD News and Press, InMode Ltd.

InMode to Report Second Quarter 2026 Financial Results on August 5, 2026, Expects Q2 Revenue Between $95.2M-$95.4M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M PR Newswire YOKNEAM, Israel , July 13, 2026 /PRNewswire/ --  InMode Ltd. (NASDAQ: INMD), a leadin...

2026-07-09 09:41:51 ET More on InMode InMode: It's Time To Exit The Theater (Rating Downgrade) InMode Ltd. (INMD) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow InMode: My Pick For A Major Turnaround In 2026 And 2027 Steel Partners comes ...

Superior Proposal Exceeds Conflicted CEO-Led $16.20 Insider Bid and Provides Optional Shareholder Rollover Demands the Board Take Immediate Action to Remove Incapable and Conflicted CEO Calls on Board to Form a Truly Independent Special Committee and Retain an Independent Investme...

2026-07-01 15:19:25 ET More on InMode InMode: It's Time To Exit The Theater (Rating Downgrade) InMode Ltd. (INMD) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow InMode: My Pick For A Major Turnaround In 2026 And 2027 InMode rises on unsol...

DOMA PERPETUAL CAPITAL MANAGEMENT STRONGLY OPPOSES INMODE BUYOUT AS PROPOSED; PLANS TO VOTE AGAINST DEAL PR Newswire DOMA ASSERTS THAT THE $16.20 PER SHARE OFFER MATERIALLY UNDERVALUES INMODE AND ITS LONG-TERM POTENTIAL DOMA BELIEVES THE BID EXPLOITS THE DEPRESSED VALUATIONS CREATE...

2026-06-25 12:20:31 ET InMode Overview This isn't the first time that InMode ( INMD ) has been subject to takeover rumors.... Read the full article on Seeking Alpha For further details see: InMode: It's Time To Exit The Theater (Rating Downgrade)

Issued on behalf of Conexeu Sciences Inc. With Galderma now presenting clinical data on treating medication-driven facial volume loss, the GLP-1 aesthetics category has gone mainstream — and Conexeu Sciences Inc. (Nasdaq: CNXU) is positioning its regenerative CXU™ platform to co...

2026-06-24 09:05:12 ET More on InMode InMode Ltd. (INMD) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow InMode: My Pick For A Major Turnaround In 2026 And 2027 InMode Ltd. (INMD) Q1 2026 Earnings Call Transcript InMode Non-GAAP EPS of $0....

InMode Confirms Receipt of Unsolicited Proposal PR Newswire YOKNEAM, Israel , June 24, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) (the "Company") today announced that, on June 17, 2026, its Board of Directors (the "Board") received an unsolicited  proposal from M.N. Bus...

2026-05-28 09:37:49 ET InMode Ltd. ( INMD ) is an Israeli company that operates mainly in the minimally-invasive aesthetics market. They have developed proprietary technology incorporating RF (radio-frequency) lipolysis and deep subdermal fractional RF procedures. Their best known i...